AN ACT ESTABLISHING A BRIDGE PROGRAM FOR EMERGENCY TREATMENT AND RECOVERY NAVIGATION FOR PERSONS WITH AN OPIOID USE DISORDER.
What changed between versions
Hospitals are now required to administer either buprenorphine or methadone to patients with opioid use disorder symptoms, whereas the original version only mandated buprenorphine.
Hospitals administering methadone must now refer patients specifically to treatment programs or community providers that are equipped to administer methadone.
The requirement to provide opioid antagonists was changed from a mandatory provision to an offer that is only fulfilled if the patient accepts.
New provisions were added to ensure nothing in the bill limits a clinician's professional judgment or requires medication if it is clinically contraindicated.
New definitions were added for 'bridging prescription' and 'last-dose letter' to formalize the documentation required when transferring patients to long-term treatment.
A new definition for 'community provider' was added to clarify which non-hospital entities can administer buprenorphine or methadone.